Key facts
- Mango Sciences’s last known valuation is $83.0M (Aug 2024).
- It has raised $16.7M across 1 recorded rounds; the latest was Seed Round ($2.7M) in Jan 2020.
- Notable investors include Octopus Ventures, Realm Capital Ventures, Kube VC, Incisive Ventures, BECO Capital — 14 tracked in total.
- Mango Sciences has filed 1 Form D with the SEC, most recently Jan 2020 ($2.7M sold to 23 investors).
- Status: Acquired/Merged (Operating Subsidiary).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Mango Sciences
Funding rounds
1 roundsAbout Mango Sciences
Operator of a market data science platform intended to solve the health challenges of underrepresented populations. The company's platform utilizes artificial intelligence analytics to transform deep clinical data into key insights and real-world evidence, improve access to life-saving care, and identify patients for clinical trials, enabling patients to have value-based financing agreements for immunotherapy drugs in emerging markets.
- Sector
- Information Technology
- HQ
- Boston, MA, United States
- Founded
- 2012
- Employees
- 48
- Website
- mangosciences.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Mango Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mango Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mango Sciences in its N-PORT filings yet. We sweep new filings monthly.